Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MDR - Comprehensive Primary Revision Stems PMCF

NCT: NCT06788717 · RECRUITING

NCT IDNCT06788717
StatusRECRUITING
Start Date2025-06-19
Completion2040-12

Brief Summary

The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.

Frequently Asked Questions

What is MDR - Comprehensive Primary Revision Stems PMCF?

MDR - Comprehensive Primary Revision Stems PMCF is a clinical trial registered under NCT06788717. Current status: RECRUITING.

What is the status of NCT06788717?

The current status of NCT06788717 (MDR - Comprehensive Primary Revision Stems PMCF) is: RECRUITING.

When did MDR - Comprehensive Primary Revision Stems PMCF start?

MDR - Comprehensive Primary Revision Stems PMCF started on 2025-06-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑